Author details

Full Name

David M Reid

Affiliation

ORCID

Career Start Year

1982

Papers

331

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36831016	CXCR2 Antagonist RIST4721 Acts as a Potent Chemotaxis Inhibitor of Mature Neutrophils Derived from Ex Vivo-Cultured Mouse Bone Marrow.		2023
35378630	UK clinical guideline for the prevention and treatment of osteoporosis.	Archives of Osteoporosis	2022
35585444	Correction: UK clinical guideline for the prevention and treatment of osteoporosis.	Archives of Osteoporosis	2022
34716902	A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis.	Dermatology and Therapy	2021
32995252	Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group.	J Bone Oncol	2020
32010237	Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?	Therapeutic Advances in Musculoskeletal Disease	2020
32353565	Zoledronate.		2020
31943121	Statistical shape modelling provides a responsive measure of morphological change in knee osteoarthritis over 12 months.	Rheumatology	2020
32547728	Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS).	Therapeutic Advances in Drug Safety	2020
29551751	Bone turnover markers after the menopause: T-score approach.		2018
29937404	A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study.	Annals of Epidemiology	2018
29673866	Significant morphological change in osteoarthritic hips identified over 6-12 months using statistical shape modelling.	Osteoarthritis and Cartilage	2018
27705888	Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).	European Heart Journal	2017
28425085	UK clinical guideline for the prevention and treatment of osteoporosis.	Archives of Osteoporosis	2017
28620421	Is there role for vitamin D in the treatment of chronic pain?	Therapeutic Advances in Musculoskeletal Disease	2017
28398504	Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.	Rheumatology (Oxford)	2017
27788053	Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy.	Journal of Clinical Endocrinology and Metabolism	2016
26834846	Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference.	Therapeutic Advances in Musculoskeletal Disease	2016
26834845	Osteoporosis therapeutics: recent developments at ASBMR.	Therapeutic Advances in Musculoskeletal Disease	2016
26866516	Brief Report: Predicting Functional Disability: One-Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort.	Arthritis and Rheumatology	2016
26944421	Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial.	Lancet Diabetes and Endocrinology,The	2016
27829394	The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank.	BMC Musculoskeletal Disorders	2016
26021761	Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.	Osteoporos Int	2015
25304911	Reproducibility and Diagnostic Accuracy of Kellgren-Lawrence Grading for Osteoarthritis Using Radiographs and Dual-Energy X-ray Absorptiometry Images.	Journal of Clinical Densitometry	2015
25640980	Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study.	Clinical Endocrinology	2015
26077380	FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.	Osteoporosis International	2015
24929635	Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study.	Rheumatology	2014
25313576	Patterns of dietary intake and serum carotenoid and tocopherol status are associated with biomarkers of chronic low-grade systemic inflammation and cardiovascular risk.	British Journal of Nutrition	2014
23775829	A meta-analysis of the association of fracture risk and body mass index in women.	J Bone Miner Res	2014
24343915	A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus.	J Med Genet	2014
23982800	A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?	Osteoporosis International	2014
24489015	Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.	Rheumatology	2014
24480136	THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women.	Eur J Endocrinol	2014
23355077	The characterisation and determinants of quality of life in ANCA associated vasculitis.	Annals of the Rheumatic Diseases	2014
25228986	Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state.		2014
25187239	Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts.	Calcif Tissue Int	2014
23365149	Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.	Rheumatology	2013
23948677	Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study.		2013
23810490	Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.		2013
24386199	FRAXÂ®: prediction of major osteoporotic fractures in women from the general population: the OPUS study.	PLoS ONE	2013
23740186	Explaining fatigue in ANCA-associated vasculitis.	Rheumatology	2013
23313107	Alternative population sampling frames produced important differences in estimates of association: a case-control study of vasculitis.	Journal of Clinical Epidemiology	2013
23308207	Seasonal variation in 25(OH)D at Aberdeen (57Â°N) and bone health indicators--could holidays in the sun and cod liver oil supplements alleviate deficiency?	PLoS ONE	2013
23585346	Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women.	Journal of Bone and Mineral Research	2013
23584367	Fatigue-related brain white matter changes in granulomatosis with polyangiitis.	Rheumatology	2013
23220597	Can we improve the prediction of hip fracture by assessing bone structure using shape and appearance modelling?		2013
22139532	Predicting OA progression to total hip replacement: can we do better than risk factors alone using active shape modelling as an imaging biomarker?	Rheumatology	2012
22850943	Professor philip sambrook - obituary.	Therapeutic Advances in Musculoskeletal Disease	2012
22349910	A European multicenter comparison of quantitative ultrasound measurement variables: the OPUS study.	Osteoporosis International	2012
22348983	Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis.		2012